Tomorrow, FDA plans to issue final guidance on Dear Health Care Professional Letters. The guidance addresses when it is appropriate to use Dear Health Care Professional Letters, what type of information should be included, how to organize the information, and formatting techniques to improve accessibility. This guidance finalizes the agency’s draft guidance on this subject issued in November 2010. You can access the advance notice in the Federal Register and the full text of the guidance below.
